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Caveolin-1 Influences LFA-1 Redistribution upon TCR
Stimulation in CD8 T Cells
Jessica G. Borger,* Vicky L. Morrison,† Andrew Filby,‡ Celine Garcia,* Liisa M. Uotila,x
Fabio Simbari,* Susanna C. Fagerholm,x and Rose Zamoyska*
TCR stimulation by peptide–MHC complexes on APCs requires precise reorganization of molecules into the area of cellular
contact to form an immunological synapse from where T cell signaling is initiated. Caveolin (Cav)1, a widely expressed trans-
membrane protein, is involved in the regulation of membrane composition, cellular polarity and trafficking, and the organization
of signal transduction pathways. The presence of Cav1 protein in T cells was identified only recently, and its function in this
context is not well understood. We show that Cav1-knockout CD8 T cells have a reduction in membrane cholesterol and
sphingomyelin, and upon TCR triggering they exhibit altered morphology and polarity, with reduced effector function compared
with Cav1 wild-type CD8 T cells. In particular, redistribution of the b2 integrin LFA-1 to the immunological synapse is compro-
mised in Cav1-knockout T cells, as is the ability of LFA-1 to form high-avidity interactions with ICAM-1. Our results identify a
role for Cav1 in membrane organization and b2 integrin function in primary CD8 T cells. The Journal of Immunology, 2017, 199:
874–884.
T
cells require integrin-mediated cell adhesion to interact
stably with APCs and initiate optimal TCR signaling and
activation (1, 2). Integrins are heterodimeric transmem-
brane proteins, composed of a and b subunits, which are capable
of bidirectional signaling across the plasma membrane. In naive
T cells, integrin binding is of low affinity, as the molecules are
mainly in a low-affinity conformation. Activation through surface
receptors, such as TCR by peptide–MHC (pMHC) molecules or
chemokine receptor by chemokine, initiates specific intracellular
signaling termed “inside-out signaling,” which drives conforma-
tional changes within the integrin subunits promoting high-affinity
binding to ligand (3–5). Lateral association of integrins into
clusters further promotes ligand binding avidity (6, 7). In turn,
“outside-in signaling,” whereby high-affinity integrin–ligand in-
teractions result in signal transmission into the cell to drive re-
organization of the actin cytoskeleton and mediate cell spreading,
increases cell–cell avidity or cell–extracellular matrix adhesion.
LFA-1 (aLb2, CD11a/CD18) and very late Ag-4 (VLA-4, a4b1,
CD49d/CD29) are the major integrins expressed on T cells. LFA-1 is
an important structural component of the immunological synapse
(IS) formed between T cell and APCs, strengthening T cell–APC
interactions and facilitating cell polarization. IS formation reduces
the threshold for T cell activation during cell-mediated immune re-
sponses (8–12). Integrins play important roles not only in mediating
IS formation but also in cell adhesion to the extracellular matrix,
contractility, motility, and growth (13–18). Under conditions of shear
flow, high-affinity LFA-1 binds ICAM-1 and -2 expressed on the
endothelial cells surrounding the blood vessels, facilitating firm
adhesion for T cell transmigration into lymph nodes. Therefore,
active LFA-1 is critical for T cell migration into secondary lymphoid
tissues and other sites of inflammation (19, 20).
Caveolin (Cav) proteins have been linked with integrin signaling in
multiple cell lineages (21). There are three Cav isoforms, Cav1 and
Cav2, which are coexpressed in most cell lineages, including adi-
pocytes, endothelial cells, epithelial cells, and fibroblasts, whereas
Cav3 is muscle cell specific (22, 23). Cav1 has a structural role
within the plasma membrane through its direct interaction with
cholesterol and lipids, maintaining lipid and cholesterol homeostasis,
and is the major structural component of caveolae (24). Caveolae are
specialized lipid raft microdomains regarded as dynamic signaling
centers in which Cav1 facilitates a variety of cellular processes
through direct protein–protein interactions with heterotrimeric G
proteins, Src family tyrosine kinases, H-Ras, endothelial NO
synthase, and the insulin receptor (25–27). In addition to its role in
caveolae, Cav1 also functions in other subcellular locations, in-
cluding the focal adhesion complex (28, 29). Initial studies failed
to detect Cav1 and caveolae in lymphocytes; however, Cav1 has
now been identified in B cells and T cells (30–32). Moreover,
Cav1 was shown to influence naive CD8 T cell activation and cell
polarity (32).
To date, there are no reports on the association of Cav1 with
integrin function in T cells, and we set out to investigate whether
Cav1 was involved LFA-1 function. We demonstrate that following
TCR engagement, Cav1-deficient CD8 T cells had altered
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morphology, polarization, and reduced adhesiveness to ICAM-1
under conditions of shear flow. Additionally, there was impaired
homotypic adhesion and impaired LFA-1 recruitment to the IS upon
TCR/pMHC association in Cav1-deficient CD8 T cells, together with
a reduction in their response to Ag. Loss of Cav1 reduced the
cholesterol and sphingomyelin content of CD8T cells, suggesting that
Cav1 plays a role in membrane lipid homeostasis, which influenced
the redistribution of LFA-1 and its avidity for ICAM-1. Taken to-
gether, these results identify a role for Cav1 in regulating TCR signals
required for LFA-1–mediated cellular adhesion and IS formation in
naive CD8 T cells.
Materials and Methods
Mice
Cav1-deficient (Cav1-knockout [KO]) mice have been described previously
(33) and were provided by B. Nichols, Cambridge University. Cav1-KO
mice were backcrossed to Rag12/2 OT-1 TCR transgenic mice. CD3ε-
deficient (CD3ε-KO) mice were bred in-house at the University of Edin-
burgh. All procedures were approved under a project license granted by the
U.K. Home Office and were carried out in accordance with the institutional
and ethical guidelines of the University of Edinburgh.
Cell preparation and in vitro analysis of T cell activation
T cell suspensions were prepared from lymph nodes of OT-1 or polyclonal
C57/BL6mice. Where stated, PE-conjugated Abs were used for purification
of naive CD8 T cells by negative selection. Lymph node cells were in-
cubated with anti–CD4-PE (eBioscience) and anti–I-A/I-E-PE (Bio-
Legend) followed by a 15-min incubation with anti-PE MACS beads
(Miltenyi Biotec). Cells were added to MACS LS columns (Miltenyi
Biotec) and nonbinding CD8 T cells were collected. Wild-type (WT) and
Cav1-KO lymph node CD8 T cells were cultured in IMDM media
(Invitrogen) supplemented with 5% FCS, L-glutamine, antibiotics, and
50 mM 2-ME. OT-1 CD8 T cells were activated by the addition of peptides
SIINFEKL (N4), SIITFEKL (T4), or SIIGFEKL (G4) in the presence of
CD3ε-KO spleen cells as APCs to culture media as indicated. At the end of
culture, CD8 T cells were stained with the relevant Abs, run through a
MACSQuant flow cytometer (Miltenyi Biotec), and analyzed with FlowJo
software (Tree Star). For proliferation assays, OT-1 T cells were labeled
with CellTrace Violet (CTV; Molecular Probes) for 10 min before washing
and culture. Proliferation was determined by assessing CTV dilution using
FlowJo software (Tree Star). For LFA-1 blocking assays, M17/4 mAb
(eBioscience) was incubated in 40-ml suspensions of 100,000 cells in 96-
well round-bottom plates and incubated at 37˚C/5% CO2.
ELISA
Cytokines were measured by ELISA with paired capture and detection
Abs, anti–TNF-a Ab and anti–IL-2 Ab from eBioscience. Plates (Nunc
MaxiSorp) were washed with 0.05% Tween 20 in PBS and blocked with
1% BSA in PBS. After the addition of 100 ml of 3,39,5,59-tetramethylbenzidine
substrate solution (Sigma-Aldrich) and 100 ml of 0.1 M H2SO4, absor-
bance was read at 450 nm with a Laboratory Systems Multiskan Ascent
plate reader.
Flow cytometry and ImageStream analysis
For flow cytometry the following conjugated Abs were used: anti–CD69-PE,
(eBioscience), anti–CD11a-PE (BioLegend), anti–TCRb-PD/Cy7 (Bio-
Legend), anti–CD18-PerCP (BD Biosciences), and anti–CD29-BV421
(BD Biosciences). Live/Dead Aqua and CTV dyes were from Life Technol-
ogies. Samples were acquired with a MACSQuant flow cytometer (Miltenyi
Biotec) and analyzed with FlowJo software (Tree Star).
For ImageStream analysis, to accurately determine the frequency and
number of 1:1 T cell/APC heteroconjugates and subsequently measure the
relative level of actin recruitment to the IS, splenocytes from CD3ε-KO
mice were labeled with 1 mM MitoTracker Deep Red FM (MitoTDR) and
then loaded with 1026 M N4 peptide for 30 min at 37˚C. T cells labeled
with 2.5 nM CTVand MitoTDR-labeled peptide-loaded APCs were mixed
1:1 in IMDM and at indicated time points were fixed in 2% paraformal-
dehyde. The cells were rinsed once, permeabilized in 0.1% Triton X-100
for 6 min at room temperature, washed three times, and incubated in
BODIPY-Fl (Molecular Probes) and CD11a-PE (BioLegend) for 60 min
at room temperature. Samples were then acquired on a fully ASSIST-
calibrated four-laser ImageStream X MKII imaging flow cytometry sys-
tem (Merck Millipore/Amins). The “high sensitivity” acquisition mode
was selected and images were collected at360 magnification. The 488-nm
(blue) laser was set to 100 mW, the 561-nm (yellow/green) laser at
100 mW, the 405-nm (violet) laser at 60 mW, and the 635-nm (red) laser
was set at 120 mW to maximize signal resolution but minimize CCD
camera saturation. Bright-field illumination was collected in channels 1
and 9. For the purpose of spectral compensation, single-stained samples
were collected with bright-field illumination and the side scatter (758 nm)
laser was turned off. Compensation was determined after acquisition using
the standard wizard embedded in the IDEAS analysis software package
(Merck Millipore/Amnis) and the associated single-stained raw image files
(Supplemental Fig. 2F). In all cases the single fluorescent populations used
for determining the coefficient of compensation were manually inspected
for autofluorescent cells and regated to exclude them as appropriate. For
experimental samples a minimum of 10,000 cells were collected excluding
cellular debris and focal calibration beads (speed beads) using a gated
threshold set on the channel 1 bright-field image. Fully stained experi-
mental samples were then converted to compensated image files using the
compensation matrix shown in Supplemental Fig. 2F. The data analysis
pipeline designed to identify true 1:1 T cell/APC heteroconjugates is
outlined in Supplemental Fig. 2A–C. Briefly, potential heteroconjugates
were identified and gated based on being dual positive for CTV (CH7) and
MitoTDR (CH11). This population was further refined using the area and
aspect ratio of the bright-field channel mask (M01). T cell/APC 1:1 het-
eroconjugates were defined and gated as having a low aspect ratio and
increased area compared with single cells. Next the total integrated in-
tensities values for BODIPY-Fl (F-actin) and CD11a-PE were used to gate
on cells that were positive for both signals prior to measuring the spatial
localization within the synapse. The synapse between the T cell and APC
was masked using the “interface” masking adaptation within the IDEAS
analysis software. The 7-aminoactinomycin D image (CH05) was used as
the cell conjugate input mask (M05) and the CTV image (CH07) as the
input mask for the cell of interest. The new mask is shown in Supplemental
Fig. 2D image panel “M” and is overlaid on various channel images to
show its suitability to mask the synapse between two cells. The mask was
generated and validated using an interactive manual process as described
elsewhere (34). To measure the recruitment of BODIPY-Fl/CD11a to the
IS (as defined by the interface mask), the “internalization” feature was
used (35). A negative internalization value indicates that most of the signal
resides outside of the synaptic area, whereas increasing positive values
correlate with an increasing proportion residing within the synaptic area.
Data are expressed as the median internalization score of the final gated
population of BODIPY-Fl/CD11a double-positive, 1:1 T cell/APC hetero-
conjugates. In all cases the final cell number measured was .100 cells.
Immunoblots
Cells were lysed in 1% Triton X-100, 0.5% n-dodecyl-b-D-maltoside,
50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM EDTA, 1 mM NaF, and
1 mM sodium orthovanadate containing protease inhibitors. Samples were
separated by NuPAGE 4–12% Bis-Tris gel electrophoresis (Life Tech-
nologies). For immunoprecipitation, lysates were immunoprecipitated with
anti-Cav1 rabbit Ab (BD Biosciences) coupled to Dynabeads protein A
(Life Technologies). Immunoprecipitates were washed with lysis buffer,
and proteins were transferred onto polyvinylidene difluoride Immobilon-
FL membranes (Millipore). Membranes were incubated in blocking
reagent (LI-COR Biosciences) before Western blotting analysis with anti-
Cav1 rabbit Ab (BD Biosciences) or anti-Cav2 mouse mAb (clone 65; BD
Biosciences). Proteins were detected with secondary Abs goat anti-mouse
A680 (Life Technologies) and goat anti-rabbit IR800 (Thermo scientific)
and visualized with an infrared imaging system (Odyssey; LI-COR Biosci-
ences). Fractionation using a subcellular fractionation kit was performed
according to the manufacturer’s instructions (Thermo Scientific).
Confocal microscopy
For adhesion of CD8 T cells to ICAM-1 for morphological studies, 10-well
multispot glass slides (Hendley-Essex, Essex, U.K.) were coated overnight
in 3 mg/ml ICAM-1 (R&D Systems). Wells were washed three times in
PBS, and 50 ml of naive CD8 T cells in serum-free media (1 3 106/ml)
treated 10 min prior with 10 mg/ml anti-CD3 (clone 2C11; R&D Systems)
or 5 mg/ml SDF-1a (R&D Systems) was added. Cells were left to attach
for 30 min at 37˚C. Wells were washed once with PBS before fixing the
cells in 4% paraformaldehyde at room temperature for 60 min. The cells
were rinsed once and then permeabilized in 0.1% Triton X-100 for 6 min at
room temperature. Cells were washed three times in PBS/2% BSA and
incubated in BODIPY-Fl (Molecular Probes), anti-Lck Ab (Cell Signaling
Technology), and anti-Ezrin Ab (EC12; Abcam) for 60 min at room
temperature. Cells were washed in PBS/2% BSA and further incubated
with species-specific anti–F(ab9)2-AF488 or AF647 conjugates (Molecular
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Probes) for 15 min at room temperature. The secondary Ab was removed
by washing three times in PBS/2% BSA and then slides were mounted
with ProLong Gold anti-fade (Molecular Probes) containing 1 mg/ml DAPI
to stain nuclei. Fluorescent specimens were analyzed with a Leica TCS
SP5 II confocal imaging system (Leica Microsystems) with lasers exciting
at 405, 488, and 647 nm with the 363 objective using LAS AP software
(Leica). All confocal analyses were multiple repeats, and at least 100
images were analyzed for each condition. Data were rendered and ana-
lyzed using Volocity 6.3 (PerkinElmer) and ImageJ (National Institutes of
Health). Pearson correlation coefficient was calculated using Volocity
software to determine the pairwise colocalization of the signals with a
Student t test used to determine statistical significance between two protein
data sets. Histograms of mean fluorescence intensity (MFI) signal and
protein distribution along the axis of the cell were rendered using the
ImageJ plug-in RGB profiler.
RNA isolation, RT-PCR, and quantitative real-time PCR
Tissue was isolated from the indicated organs of one mouse, added to
TRIzol (Invitrogen), and homogenized in a TissueLyser II (Qiagen). RNA
was extracted using 1:5 chloroform. Isoproanol was added ∼1:1 to the
aqueous phase with 30 mg GlycoBlue (Invitrogen). Following a 10-min
incubation at room temperature, the centrifuged pellet was washed in 75%
EtOH and allowed to dry. Pellets were resuspended in 20 ml of DNase/
RNase-free water and quantitated on the RNA-40 program of the Nano-
Drop (NanoDrop Instruments). Reverse transcription of RNA was per-
formed with miScript II (Qiagen). Quantitative PCR was performed with
SYBR Green (Qiagen) using the following primer pairs, Cav1 forward, 59-
AACGACGACGTGGTCAAGA-39, reverse, 59-CACAGTGAAGGTGGT-
GAAGC-39; Cav2 forward, 59-ATGACGCCTACAGCCACCACAG-39,
reverse, 59-GCAAACAGGATACCCGCAATG-39; polymerase chain 1 and
transcript release factor (PTRF) forward, 59-GAAAGAAAGGCGAGTGA-
39, PTRF reverse, 59-TAATGTGTAAGTGCC CCTG-39, and normalized to
the abundance of 18S mRNA.
Aggregation assay
CD8 T cells were resuspended in IMDM supplemented with 10% FCS and
40 mM HEPES at a cell density of 15 3 106 cells/ml and aliquoted into
96-well plates at 200 ml/well. Cells were activated in 50 ng/ml phorbol
dibutyrate (PdBu; Sigma-Aldrich) or 1 mg/ml anti-CD3 mAb (clone 2C11;
R&D Systems) for 60 min to allow for conjugate formation. Samples (20
ml) were taken in triplicate and the number of free cells counted. Aggre-
gation percentage was calculated as previously described in Fagerholm
et al. (36); that is, the number of free cells after stimulation subtracted from
the number of free cells in unstimulated samples, divided by the number of
free cells in the unstimulated samples.
Cell attachment assays
For static adhesion assays, ICAM-1 (6 mg/ml; R&D Systems) was coated
onto 96-well MaxiSorp plates (Nunc) by overnight incubation at 4˚C, and
the wells were blocked with 1% milk in PBS. Lymphocytes from Cav1-
WT or Cav1-KO mice were resuspended in adhesion medium (RPMI 1640
supplemented with 0.1% BSA, 40 mM HEPES, and 2 mM MgCl2) and
added to the plate. Where appropriate, cells were stimulated with 200 nM
PdBu (Sigma-Aldrich), 10 mg/ml anti-CD3 (R&D Systems), or 1 mg/ml
SDF-1a (R&D Systems) immediately before being added to the plate.
Cells were allowed to adhere for 30 min at 37˚C. Unbound cells were
removed by gentle washing in PBS plus 2 mM MgCl2, and bound cells
were lysed and detected with phosphatase substrate (Sigma-Aldrich).
For shear flow adhesion assays, VI0.4 m-slides (Ibidi) were coated with
6 mg/ml murine ICAM-1 (R&D Systems) overnight at 4˚C. Where indi-
cated, SDF-1a (R&D Systems) was coimmobilized by addition of 5 mg/ml
onto plates for a further 30 min at 37˚C. T cells were prepared at a density
of 1 3 106 cells/ml in binding medium (RPMI plus 0.1% BSA, 40 mM
HEPES, and 2 mM MgCl2) and, where indicated, were stimulated with 10
mg/ml anti-CD3 (clone 2C11; R&D Systems) for 5 min. Cells were in-
jected into a flow system that used a silicone tubing loop connected to a
Multi-Phaser NE-1000 syringe pump (New Era Pump Systems), allowing
the cells to flow at a continuous shear flow rate of 0.3 dyne/cm2. Cells were
monitored by microscopy during a 10-min period, and the number of
adhered cells in the field of view was determined at 1-min intervals by
manual counting.
LFA-1 affinity modulation assay
CD8 T cells (4 3 106/ml) were washed and resuspended in HEPES buffer
(20 mM HEPES, 140 mM NaCl, 2 g/l glucose) with 0.1% BSA. Where
required, 96-well flat-bottom flexiwell plates were coated with 10 mg/ml
anti-CD3 (clone 2C11; R&D Systems) at 4˚C overnight. T cell aliquots of
50 ml (2 3 105) were added to flexiwell plates (Dynatech, West Sussex,
U.K.) with or without 5 mM Mg2+ and 1 mM EGTA. Soluble murine
ICAM-1–Fc (10 mg/ml) was added to the cells in addition to 50 ng/ml
PdBu, 100 mM N4, or 2 mg/ml anti-CD28 (R&D Systems). After 30 min
incubation at 37˚C, T cells were washed twice in ice-cold assay buffer with
0.1% BSA and incubated with 0.1 mg/ml Fc-specific FITC-conjugated goat
anti-human IgG (Jackson ImmunoResearch Laboratories, West Grove, PA)
for 20 min on ice. Cells were washed twice in ice-cold assay buffer with
0.1% BSA to remove excess unbound mAb and fluorescence was detected
with a MACSQuant (Miltenyi Biotec) flow cytometer.
Liquid chromatography–mass spectrometry analysis
Sphingolipids were first extracted from 60 mg of purified CD8 T cells (total
protein amount). After injection, samples were recovered and sphingolipids
were extracted after alkaline saponification (1 M KOH in MeOH). Prior
to the lipid extraction, 0.2 nmol synthetic standards (Avanti Polar Lipids)
were used to spike each sample to normalize the results and to obtain a
relative quantification. As internal nonnatural sphingolipid standards,
N-dodecanoylsphingosine and N-dodecanoylglucosylsphingosine were used for
ceramide and glucosyl-ceramide, respectively, and N-dodecanoylsphingosyl
phosphorylcholine was the standard chosen for sphingomyelin.
Cholesterol assay
Cholesterol levels were measured in purified CD8 T cells (5 mg protein
content) using the Amplex Red cholesterol assay kit (Life Technologies)
according to the manufacturer’s instructions.
Statistical analysis
A Student t test (paired or unpaired, two tails) and ANOVAwere performed
using Prism 5.0 (GraphPad Software).
Results
Cav1 regulates the lipid composition and Ag response of CD8
T cells
Cav1 was recently shown to be expressed in T cells, having pre-
viously been described as absent in T cell lines (37–40), and was
shown to influence actin polymerization, synaptic membrane raft
polarity, and CD8 T cell function (32). It was unclear whether
T cells also expressed Cav2, which is frequently hetero-
oligomerized with Cav1. Cav1 is a homodimeric transmembrane
protein expressed in two isoforms, Cav1a and Cav1b, derived
from alternate translation–initiation sites commencing transcrip-
tion from a methionine at positions 1 and 32, respectively (41).
Comparing lysates of purified CD8 T cells from naive C57BL/6
WT and Cav1-KO CD8 T cells, we confirmed that both isoforms
of Cav1 were present in WT cells with a preponderance of the a
isoform (Fig. 1A). Both isoforms, a and b, of Cav2 were also
expressed in naive WT CD8 T cells. Cav2 could be immunopre-
cipated with Cav1, as described in other cell types (22). The
abundance of Cav2 was greatly reduced in Cav1-KO CD8 T cells
(Fig. 1A), consistent with reports showing that when not oligo-
merized with Cav1, Cav2 was rapidly degraded by the proteosome
(42). Cav1, Cav2, and the other critical component of caveolae,
cavin/PTRF, were expressed in considerably lower abundance in
the thymus and secondary lymphoid organs compared with lung
and adipose tissue (Supplemental Fig. 1A–C). As previously
suggested (37–40), we could not identify any caveolae-like struc-
tures in naive CD8 T cells whereas they could be seen by electron
microscopy in A431 cells (Supplemental Fig. 1D), confirming that
Cav1 in T cells was not associated with caveolae.
Cav1 is found within all membranes of the cell and is also involved
in the shuttling of cholesterol from the endoplasmic reticulum to the
plasma membrane, directing Cav1 to cholesterol and sphingolipid-
enriched membrane domains (43, 44). We asked where Cav1 lo-
calized within naive CD8 T cells and found that ∼50% of Cav1
protein localized within the membrane-soluble fraction of naive CD8
T cells, with the remaining Cav1 protein found within the insoluble
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cell pellet, containing lipid–cytoskeletal complexes (Fig. 1B). Upon
in vitro stimulation of T cells with anti-CD3 Ab for 48 h, Cav1
wholly redistributed within lipid–cytoskeletal complex fractions
(Fig. 1B). Redistribution of Cav1 appeared to be driven by in vitro
TCR activation, as it was less evident in cells cultured in the cyto-
kine IL-7, which maintains T cell viability without stimulating
proliferation (Fig. 1B).
Given that Cav1 directly binds cholesterol and specific sphingolipids,
we asked whether the lipid composition was altered in naive CD8
T cells in the absence of Cav1 by performing lipidomic analysis.
Sphingomyelin, one of themost abundant sphingolipids in cells and a
major component of lipid rafts, was significantly reduced in naive
CD8 T cells in the absence of Cav1 (Fig. 1C). Furthermore, analysis
of individual sphingomyelin species revealed a marked reduction in
short fatty acids in Cav1-KO CD8 T cells (Fig. 1D). Additionally,
there was a significant decrease in the abundance of free cholesterol
in Cav1-KO naive CD8 T cells compared with WT cells (Fig. 1E). In
contrast, Cer and GluCer, other classes of sphingolipids, were not
reduced in the absence of Cav1 (Fig. 1F, 1G), which suggested a role
for Cav1 in the transport of specific lipids to the plasma membrane in
CD8 T cells.
The abundance of cholesterol in the plasma membrane has been
linked directly to the ability of CD8 T cells to respond to Ag (45), so
we crossed Cav1-KO mice onto the OT-1 class 1 MHC–restricted,
TCR transgenic background to enable interrogation of Ag-specific
CD8 T cell responses. Responses of Cav1-WT and Cav1-KO OT-1
CD8 T cells were measured to a range of peptides of differing af-
finities: N4, a strong agonist; T4, a partial agonist; and G4, a very
weak agonist. We confirmed that loss of Cav1 impaired the response
of CD8 T cells to TCR/pMHC stimulation in vitro (Fig. 2), as
previously reported for polyclonal CD8 T cells stimulated with
anti-CD3/28 Abs (32). The absence of Cav1 had a significant
impact on the upregulation of the early activation marker CD69
for all altered peptide ligands (Fig. 2A) and resulted in a sig-
nificant reduction in the development of effector function, as
measured by the production of cytokines IL-2 and TNF-a
(Fig. 2B, 2C) and, as previously described (32), IFN-g (data not
shown). Although activation and effector functions were signifi-
cantly impacted by Cav1 deficiency, there was only a subtle reduction
in proliferation in Cav1-KO CD8 T cells (Fig. 2D). At first sight,
these data appear to contradict a previous report (32) showing that
Cav-KO CD8 T cells have reduced proliferation to anti–CD3 plus
CD28 stimulation in vitro and expansion to lymphocytic chorio-
meningitis virus in vivo. However, Tomassian et al. (32) showed that
whereas a reduced proportion of Cav-KO CD8 T cells had entered
division by 48 h, there was no defect in their ability to undergo
multiple divisions. In contrast to anti–CD3 plus CD28 stimulation,
the strong agonist N4 peptide drives all the OT-1 T cells synchro-
nously into division in vitro, and therefore the strength of the stimulus
would be likely to minimize any differences in proliferation between
WT and KO T cells so that although there was a trend for less pro-
liferation in the Cav1-KOs, this was not significant over multiple
experiments. Overall, our data confirm that even though Cav1 was
expressed at much lower abundance in T cells than in nonlymphoid
tissues and was not associated with caveolae, Cav1 influenced the
lipid composition of CD8 T cell membranes, and its absence im-
paired the activation and the development of effector function of CD8
T cells upon stimulation with Ag.
Cav1 influences CD11a recruitment to the IS
A critical first step in the activation of T cells is the formation of an IS,
a specialized junction between the T cell and the APC. Recent ev-
FIGURE 1. Cav1 is localized within
soluble and insoluble membrane frac-
tions and regulates cholesterol and lipid
composition. (A) Cav1 and Cav2 pro-
tein expression was compared between
WT and Cav1-KO CD8 T cell lysates
by Western blot with anti-Cav1 and
Cav2 Ab. Cell lysates were immuno-
precipitated with anti-Cav1 and West-
ern blots were probed sequentially with
anti-Cav1 and Cav2 Ab. (B) Cell ly-
sates were separated into subcellular
fractions (C, cytoplasmic; MS, mem-
brane soluble; NS, nuclear soluble;
CB, chromatin bound; LCC, lipid-cy-
toskeletal complexes) and analyzed by
Western blot with anti-Cav1 Ab. (C)
Total sphingomyelin content in WT
versus Cav1-KO CD8 T cells. (D)
Sphingomyelin species 14:0 and 16:0
are represented as a percentage of total
sphingomyelin. (E) Free cholesterol
from WTand Cav1-KO CD8 T cells is
representative of one of three inde-
pendent experiments from a total of 12
biological samples of each genotype.
(F) Total ceramide and (G) ceramide
monohexamide content. Lipidomics
data are pooled from three biological
repeats. Data are shown as mean + SD.
*p# 0.05, **p# 0.01 (Student t test).
ns, not significant.
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idence has shown that the IS comprises a highly dynamic periphery in
which TCRs in microvesicles engage with intracellular signaling
molecules (8) whereas the structure is stabilized by a peripheral ring
(pSMAC) composed of the integrin LFA-1 interacting with its ligand
ICAM1. To assess whether the reduced activation of Cav1-KO CD8
T cells was linked to changes in IS formation, we used a high-
throughput imaging flow cytometer, ImageStream, to obtain a mea-
sure of the spatial distribution of LFA-1 (CD11a) from a large number
of conjugates over multiple early time points. Details of spillover
coefficients and the analytical and masking workflow used in the
analysis are provided in Supplemental Fig. 2. Both Cav1-WT and
Cav1-KO naive OT-I CD8 T cells formed conjugates with N4-pulsed
APCs during the 20-min observation period compared with unpulsed
controls (Fig. 3A). LFA-1 surface expression was homogeneously
dispersed on unconjugated CD8 T cells and on conjugates formed
with APCs in the absence of Ag (unpulsed) in both control and Cav1-
KO CD8 T cells. Upon T cell conjugation with N4-pulsed APCs, both
F-actin and CD11a redistributed to the IS in Cav1-WT and Cav1-KO
CD8 T cells. Calculation of the internalization score, the amount of
protein within the cell–cell contact area, revealed a reduction of both
F-actin and CD11a recruitment to the IS in the absence of Cav1 (Fig.
3B, 3C), as seen clearly at the 20 min time point shown in Fig. 3A.
Cav1 alters T cell morphology and polarization
Less LFA-1 was recruited to the IS in the absence of Cav1, which
could result from Cav1 directly influencing LFA-1 signaling, as Cav1
is known to influence integrin signaling in other cell types (46–48),
or as an indirect effect arising from defective TCR stimulation of
inside-out signaling to LFA-1. To better understand how lack of
Cav1 influenced LFA-1 interactions with ICAM-1, we looked at the
consequences on cell morphology and distribution of particular in-
tracellular signaling molecules following LFA-1 interaction with
immobilized ICAM-1. Naive OT-1 CD8 T cells require either TCR
or chemokine CXCR4 stimulation to induce a conformational
change in LFA-1 to its active, high-affinity conformation. Cav1-WT
and Cav1-KO CD8 T cells were activated with anti-CD3 Ab or SDF-
1a (CXCL12), the ligand for CXCR4, for 10 min prior to addition to
glass slides coated with ICAM-1. Resting T cells have a spherical
morphology with F-actin homogeneously distributed around the
plasma membrane, as shown by both Cav1-WT and Cav1-KO CD8
T cells (Fig. 4A). After 10 min of anti-CD3 stimulation, Cav1-WT
and Cav1-KO CD8 T cells were attached to ICAM-1–coated glass
coverslips for 30 min, whereupon Cav1-WT cells became polarized
and formed the characteristic F-actin extensions at one pole. However,
Cav1-KO CD8 T cells lacked a defined uropod structure (Fig. 4A).
Calculation of the surface area of the anti–CD3 Ab-stimulated cells
showed that Cav1-KO CD8 T cells had spread significantly less, with
a reduced area and mean of the longest axis, than did their WT
counterparts (Fig. 4B, 4C). Accordingly, the shape factor was signif-
icantly lower in Cav1-KO CD8 T cells, as the cells were more circular
than theWT cells, which formed distinct uropod protrusions (Fig. 4D).
Cav1 deficiency has been reported to cause Src-dependent re-
moval of focal adhesions from cell edges in fibroblast cells (49). We
therefore asked whether loss of morphology was indicative of aber-
rant polarity of TCR-stimulated CD8 T cells upon LFA-1 inter-
action with ICAM-1. Ezrin, one of the ezrin-radixin-moesin proteins
that links the plasma membrane to the actomyosin cortex and
modulates T cell polarization through regulating cortical tension
(50), was found to be concentrated within the defined uropod of
Cav1-WT CD8 T cells following TCR stimulation (Fig. 4E).
Strikingly, Ezrin remained homogeneously localized around the
cell periphery in Cav1-KO CD8 T cells. Loss of Lck clustering
with the TCR following early activation of Cav1-KO regulatory
T cells was reported recently (51), suggesting that Lck localization
at the leading edge of migrating T cells could be impeded in Cav1-
KO CD8 T cells. Indeed, we found that although Cav1-WT CD8
T cells polarized Lck to the leading edge, in Cav1-KO cells Lck
maintained a homogenous distribution around the cell membrane.
To visualize the proportion of molecules that redistributed toward
the uropod and leading edge of TCR-stimulated CD8 T cells, we
used spectral overlaps and RGB histogram analysis. A merge
image sectioned from the leading edge (designated by an asterisk)
to the opposing uropod (trajectory represented by a white line)
showed that in Cav1-WT CD8 T cells, most Lck was polarized to
the leading edge of the migrating cell, with most Ezrin molecules
concentrated within the uropod (Fig. 4F). Analysis of Cav1-KO
CD8 T cells identified a similar proportion of Lck and Ezrin
molecules within both the leading edge and uropod. A comparison
of the Pearson correlation coefficient between Lck and Ezrin
revealed that following TCR stimulation, Cav1-WT CD8 T cells
have a significantly lower level of protein colocalization than do
Cav1-KO cells (Fig. 4G). Taken together, these results show that
Cav1 plays a role downstream of the TCR in maintaining T cell
morphology and directing cellular polarization upon LFA-1–mediated
cellular adhesion of CD8 T cells.
Impaired adhesion to ICAM-1 under conditions of shear flow in
the absence of Cav1
The altered morphology and polarization of Cav1-KO CD8
T cells interacting with ICAM-1 led us to first analyze cell ad-
hesion using a static adhesion assay in which the capacity of cells
to adhere to ligand in the absence of shear flow is quantified.
Adhesion of Cav1-KO CD8 T cells to immobilized ICAM-1 was
comparable to that observed inWT cells, whether cells were untreated
or stimulated with phorbol esters (PdBu), TCR, or chemokine ligands
(Fig. 5A).
FIGURE 2. Cav1 regulates CD8 T cell responses to Ag. (A) The fre-
quency of CD69+ cells among Cav1-WT and Cav1-KO OT-1 CD8 T cells
stimulated for 3 h with a titration of N4, T4, or G4 peptides. (B and C)
Cav1-WT and Cav1-KO OT-1 CD8 T cells were stimulated and superna-
tants were assayed at 24 h for total IL-2 (B) and TNF-a (C) by ELISA. (D)
Proliferation at 72 h of CTV-labeled OT-1 T cells is represented by the
division index calculated using FlowJo software. Data are representative of
two independent experiments, each performed on three mice per group.
Error bars represent SD. *p # 0.05, **p # 0.01, ***p # 0.001 (Student t
test, corrected for multiple comparisons using the Holm–Sidak method).
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Integrins mediate cell adhesion under shear flow conditions and
are essential for the adhesion of T cells to high endothelial venules,
a process that is dependent on high-affinity LFA-1 interactions with
ICAM-1. Both external (shear-based) and internal (cytoskeleton-
based) forces contribute to LFA-1–ICAM-1 interactions and integ-
rin activity (52). We asked whether the absence of Cav1 influenced
adhesion of naive CD8 T cells to immobilized ICAM-1 under
conditions of fluid shear stress. Following preincubation with anti-
CD3 or SDF-1a, T cells were allowed to flow over plates coated
with ICAM-1 alone at the shear rate of 0.3 dyne/cm2. The initial
transient low-affinity interaction between T cells and endothelium
in vivo is mediated mainly through P- and L-selectin and results in
T cell rolling. We did not include selectins in this assay so that we
could assess rolling as a direct measure of low to intermediate
affinity LFA-1–ICAM-1 interactions, which occur at strengths too
weak to allow firm attachment. Rolling rates of WT and Cav1-KO
CD8 T cells were comparable following either TCR or SDF-1a
stimulation (Fig. 5B), indicating that these weak LFA-1–ICAM-1
affinities were unaffected by the loss of Cav1. However, when we
tested whether the cells could form firm attachments by measuring
the number of adherent cells under conditions of flow, we found that
the Cav-1KO CD8 T cells were 40% less adherent than WT cells to
ICAM-1 (Fig. 5C). This difference was only observed following
anti-CD3 stimulation of the cells and was not apparent following
stimulation with the chemokine SDF-1a. These data indicate that
the TCR signals that license high-avidity interactions of LFA-1 with
ICAM-1 are compromised in Cav1-KO CD8 T cells.
High-avidity interactions between LFA-1 and ICAM-1 are the
result of both conformational changes in the LFA molecules
themselves, which lead to higher affinity binding termed “affinity
modulation,” and changes in local integrin density, which increase
valency and result in “avidity modulation.” To ask whether loss of
Cav1 impaired LFA-1 affinity modulation, we first examined naive
OT-1 CD8 T cell adhesion to soluble ICAM-1 following activation
of LFA-1 directly. Treatment of the cells with the divalent cation
Mg2+ in the presence of EGTA, to prevent Ca2+-dependent changes in
avidity, can be used to increase LFA-1 affinity (53, 54). When LFA-1
was in a low-affinity state (HEPES buffer only) the amount of
soluble ICAM-1 binding was low and equivalent in Cav1-WT and
Cav1-KO CD8 T cells (Fig. 5D, 5E). Addition of Mg2+/EGTA
caused only a negligible and comparable MFI shift in ICAM-1
binding to both Cav1-WT and Cav1-KO CD8 T cells. We next
addressed the ability of CD8 T cells to bind ICAM-1 following
stimulation with PdBu, peptide (N4), anti-CD3 Ab or anti-CD3 plus
soluble anti-CD28 Abs (CD3/28). After 30 min stimulation, adhe-
sion of soluble ICAM-1 was enhanced in a comparable manner for
Cav1-WT and Cav1-KO CD8 T cells and both bound ICAM-1
maximally following stimulation with PdBu and anti-CD3/28 treat-
ment. These data indicate that there is no defect in upregulation of
LFA-1 affinity following TCR stimulation in Cav1-KO CD8 T cells
and suggest instead that compared with Cav1-WT, Cav1-KO cells
may not be able to redistribute LFA-1 as effectively to promote high-
avidity LFA-1–ICAM-1 interactions.
Impaired LFA-1–mediated aggregation in the absence of Cav1
ICAM-1 is expressed on the surface of T cells, and in culture LFA-1
mediates cell–cell adhesion by binding in trans to this ligand in
response to stimuli, including PdBu (55, 56). Thus, activation of
LFA-1 can lead to the formation of aggregates of homotypically
adherent cells (57), which is considered to be a reflection of ligand-
dependent redistribution of LFA-1 molecules (58). We examined the
ability of purified CD8 T cells to form aggregates following stim-
ulation with anti-CD3 or with PdBu plus ionomycin, which activates
integrins while bypassing TCR-proximal signaling (Fig. 6A). The
percentage of naive OT-1 CD8 T cells that formed aggregates after
60 min was significantly lower in Cav1-KO T cell cultures compared
with Cav1-WT cultures in response to anti-CD3. In contrast, PdBu
plus ionomycin stimulation caused equivalent aggregation. Reduced
aggregation in the absence of Cav1 was not due to altered expression
of adhesion molecules on Cav1KO CD8 T cells, as phenotyping for
surface markers confirmed that there was equivalent abundance of
both the aL (CD11a) and b2 (CD18) chains of LFA-1, as well as
other adhesion molecules, including the b1 integrin CD29 (VLA4)
together with the TCR complex (Fig. 6B). By 24 h after activation,
FIGURE 3. Impaired recruitment
of F-actin and CD11a to the IS in the
absence of Cav1. ImageStream anal-
ysis assessing conjugate formation of
Cav1-WT or Cav1-KO OT-1 CD8
T cells with N4-pulsed APCs for the
indicated times (0–20 min) is shown.
Original magnification 360. Conju-
gates were fixed, permeabilized, and
stained for BODIPY-Fl (F-actin, green)
and CD11a (yellow). (A) The four rows
show representative cells at 20 min, with
distribution of BODIPY-Fl and CD11a
within the synapse formed between
T cells (purple) and APCs (red) shown
in merge columns 4 and 5, respectively.
Graphs of the internalization method,
previously described in (35), for Cav1-
WT and Cav1-KO conjugates stained
with (B) BODIPY-Fl and (C) CD11a
are representative of three independent
experiments.
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CD8 T cells formed large clusters that were comparable in size
between Cav1-KO and Cav1-WT cells (Fig. 6C, 6D). These data
indicate that in CD8 T cells, Cav1 plays a role in LFA-1–ICAM-1-
dependent cell interactions early after stimulation but it does not
impact later aggregate formation, consistent with Cav1 impairing
some aspects of T cell activation (Fig. 2).
LFA-1–mediated homotypic aggregation has been linked to op-
timal activation of T cells in vitro (59–61), and combined with our
observations that there was reduced LFA-1 recruitment to the IS
(Fig. 3) suggested that a failure to form early stable LFA-1–ICAM-1
interactions could contribute to the impaired responses to Ag of
Cav1-KO OT-1 CD8 T cells. To assess this, we examined the effect
on activation with N4 peptide of disrupted T cell/APC conjugates by
addition of blocking LFA-1 mAb. CD69 upregulation, normalized
against cells stimulated without blocking Ab, was measured at 3 h.
We found that Cav1-KO CD8 T cells were more readily inhibited
than Cav1-WT cells by addition of anti–LFA-1 Ab at all time points
up to 120 min after peptide stimulation (Fig. 6E). Moreover, titration
of the blocking anti–LFA-1 Ab showed that Cav1-KO CD8 T cells
were inhibited by lower concentrations of Ab than were Cav1-
WT cells (Fig. 6F). Taken together, these data suggest that Cav1
plays a role in the dynamic regulation of molecules within T cell
membranes, and in particular influences LFA-1 redistribution to the
IS and thus the avidity of its interaction with ligand with consequent
impairment of T cell activation.
Discussion
Cav1 has been shown to influence membrane dynamics and
modulate cell adhesion, cytoskeletal organization, and polarity in a
variety of cell types (62, 63). In this study, we show that lack of
Cav1 in primary CD8 T cells directly impacted the lipid content of
the T cell membrane, with a specific overall reduction in the
abundance of short-chain fatty acid sphingomyelins and choles-
terol. Additionally, Cav1-KO CD8 T cells showed several changes
FIGURE 4. Absence of Cav1 alters CD8 T cell morphology
and polarization upon adhesion to ICAM-1. Cav1-WT and
Cav1-KO OT-1 CD8 T cells were allowed to adhere for 30 min
to glass slides with and without 3 mg/ml ICAM-1 coating. (A)
Cells were stained with BODIPY-Fl (green) to define the cell
perimeter. Cav1-WT and Cav1-KO CD8 T cells spreading on
ICAM-1 were quantified in terms of (B) area, (C) longest axis,
and (D) shape factor. For shape factor, a value of 1 is circular.
(B–D) Small horizontal lines indicate the mean. (E and F) Cells
were stained with Ezrin (green) and Lck (red). Merge images
were sectioned (white line) from the leading edge, indicated
by the asterisk, to the uropod, generating an RGB histogram
using ImageJ software. The histogram line indicates the dis-
tribution and MFI of proteins throughout the cross-section of
the cell. (G) A Pearson correlation coefficient was calculated
by Volocity software, and p values were calculated by the
Student t test. Data are representative of one of three inde-
pendent experiments with a minimum of 100 cells per con-
dition. Scale bars, 1 mm. ****p # 0.001.
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from WT T cells upon stimulation through the TCR, including an
altered morphology and an inability to appropriately redistribute
key molecules, including integrins and Lck. Moreover, Cav1-KO
CD8 T cells responded less efficiently to Ag stimulation and
showed defects in the acquisition of effector function, as has been
documented previously (32).
Our data suggest that Cav1 plays a role in influencing the dis-
tribution of molecules in the plasma membrane following TCR
stimulation. Migrating T cells establish a polarized morphology,
with an actin-rich leading edge and a uropod formed at the trailing
edge, which is required for efficient crawling. LFA-1 distributes
between both poles of the cell, participating in the pulling or
pushing of the cell within the migrating gradient. Similarly, during
cell migration Cav1 has been reported to accumulate at the anterior,
leading edge of cultured fibroblasts (64), smooth muscle cells (65),
and endothelial cells (66), as well as at the posterior, trailing edge
of bovine aortic endothelial cells and fibroblasts (67, 68). Fur-
thermore, Cav1 has been shown to influence cell polarity directly.
Cav1-deficient fibroblasts displayed loss of polarized cell mor-
phology with associated removal of focal adhesions at cell edges
and loss of directional cell migration upon stimulation, defining an
essential role for Cav1 in cell adhesion and motility of fibroblasts
(49). We found that Cav1-KO CD8 T cells displayed reduced
spreading with altered cellular morphology upon interaction with
ICAM-1. Our data indicate that Cav1 is involved also in CD8
T cell polarity, as uropod formation was compromised in TCR-
stimulated Cav1-KO cells migrating on ICAM-1, as was the re-
distribution of Ezrin and Lck. Flotillins (caveolae-associated
membrane proteins) have been shown to have a role in uropod
formation in neutrophils through direct interactions with the cor-
tical cytoskeleton through myosin-IIa (69). Indeed, Filamin-A, a
ligand of Cav1, has been shown to interact with b2 and b3
integrins through cytoskeletal association (70–73). Using coim-
munoprecipitation followed by Western blot, we were unable to
detect a direct association between Cav1 and Filamin A, Csk, Fyn,
or CD18, all of which have been implicated in mediating TCR-
induced signals in T cells and in regulating membrane dynamics
in association with Cav1 in other cell models (74–77). However,
owing to the very low abundance of Cav1 in primary T cells
compared with other cell types, the association of other mole-
cules with Cav1 may be below the level of detection by these
biochemical assays.
Cav1 has been shown to impact membrane dynamics by directly
binding cholesterol and sphingolipids at the plasma membrane
(44, 62) or through coordination of signaling proteins that regulate
the actin cytoskeleton (62, 78). Moreover, Cav1 has been shown
to transport cholesterol from the endoplasmic reticulum to the
plasma membrane in fibroblasts, thereby regulating the abundance
of cholesterol in the plasma membrane (44). The reduction in the
abundance of cholesterol and sphingolipids in Cav1-KO CD8
FIGURE 5. Impaired adhesion to
ICAM-1 under conditions of fluid
shear stress in the absence of Cav1.
(A) Static adhesion of WT (filled
bars) versus Cav1-KO (open bars)
CD8 T cells to ICAM-1. CD8 T cells
were stimulated with 50 nM PdBu,
1 mg/ml anti-CD3 Ab, or 5 mg/ml
SDF-1a before the start of the assay.
Fluid shear flow rates were set at 0.3
dyne/cm2. (B) Rolling rates of the
cells were analyzed in parallel with
(C) the number of adherent cells.
Data are shown as mean 6 SEM of
data pooled from two independent
experiments, each performed in trip-
licate on two mice per group. *p #
0.05, **p # 0.01, ***p # 0.001
(Student t test). (D) Cav1-WT or
Cav1-KO OT-1 CD8 T cells were
incubated for 30 min with chimeric
ICAM-1 in HEPES buffer alone or
supplemented with 100 nM Mg2+, or
stimulated with PdBu, N4 peptide,
anti-CD3, or anti-CD3 plus anti-
CD28, as indicated. ICAM-1 bound
to T cells was detected by staining
with human IgG-FITC. ICAM-1MFI6
SEM from one of three independent
experiments. (E) Representative histo-
grams from each condition, as indi-
cated. ns, not significant.
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T cells suggested that Cav1 might play a similar role in T cells.
Upon activation we observed Cav1 redistribution from the plasma
membrane, in naive T cells, to an almost exclusive location within
a detergent-resistant cellular pellet that is highly enriched in lipids
and cytoskeletal components, consistent with a dynamic role for
Cav1 in membrane homeostasis.
In CD8 T cells the abundance of cholesterol in the membrane
directly influences T cell function, with increased cholesterol
potentiating effector function and, conversely, depletion of cholesterol-
impairing function (45). Thus, the reduced responsiveness of Cav1-KO
OT-1 T cells is consistent with the reduction in cholesterol and
sphingomyelin content of the cells we observed. LFA-1 has been
postulated to associate specifically with a subset of lipid rafts that
are high in cholesterol in primary T cells, and this association
regulated clustering and LFA-1–mediated adhesion (79). Other
studies also correlated LFA-1 activity and lipid raft localization by
showing the clustering of high-affinity LFA-1 (by exposure to the
divalent cation Mn2+ or following domain I removal) and high-
avidity LFA-1 (by exposure to PdBu) within lipid rafts, as well as
the exclusion of inactivated LFA-1 by actin cytoskeleton associations
(80–82). Our data are most consistent with the absence of Cav1
influencing LFA-1 avidity, which is promoted by redistribution and
thus increased valency, rather than by changes in affinity arising
from repositioning or conformation of the integrin I domains to
regulate LFA-1 adhesion. We found that in Cav1-KO CD8 T cells
the CD11a subunit of LFA-1 as well as F-actin were less efficiently
relocated to the IS, which is an area high in lipid raft content,
supporting the view that Cav1 may be involved in organization of
these signaling-rich regions in T cells. A lessening in LFA-1 avidity
would also account for the reduction in homotypic adhesion and
reduced adhesion under flow observed after TCR stimulation of
Cav1-KO T cells. Collectively, this reduction in LFA-1 adhesion was
insufficient to abort T cell signaling but could account for the im-
pairment in T cell responses to Ag as shown in this study and pre-
viously (32).
The inability to detect caveolae-like structures on naive CD8
T cells and the relatively low levels of Cav1, Cav2, and PTRF
transcript in lymphoid organs compared with adipose tissue, which
is enriched in the specialized membrane microdomains, suggest
that in T cells, Cav1 plays a distinctly different role than in other
FIGURE 6. Impaired LFA-1–me-
diated CD8 T cell homotypic aggre-
gation in the absence of Cav1. (A)
Purified Cav1-WT (filled bars) and
Cav1-KO (open bars) OT-1 CD8
T cells were activated with 50 ng/ml
PdBu or 1 mg/ml anti-CD3 for 60 min
and assessed for cell–cell aggregation.
Data are shown as a mean 6 SEM
of data representing one of five in-
dependent experiments with each count
performed in triplicate on two to four
mice per group. (B) Expression levels
of the indicated surface proteins in WT
(gray shaded) and Cav1-KO (black
line) naive OT-1 CD8 T cells. Data are
representative of 25 mice per group.
Naive CD8 T cells were cultured for
24 h and then (C) imaged and (D)
assessed for cluster size using Volocity
software. Data are pooled from two
independent experiments with a mini-
mum of 100 cells per condition (mean
and SD). Scale bars, 5 mm. (E) Anti–
LFA-1 blocking mAb was added at
various time points or (F) at various
concentrations, following 1 mM N4
peptide stimulation of Cav1-WT and
Cav1-KO CD8 T cells. Inhibition of
CD69 upregulation (percentage inhi-
bition) was measured at 3 h. Data are
representative of one of three inde-
pendent experiments. *p # 0.05,
**p # 0.01, ***p # 0.001, ****p 5
0.0001 (Student t test); ns, not sig-
nificant.
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cell types where its main role is in caveolae formation. Indeed, the
combination of proteomics with subdiffraction-limit microscopy
has confirmed that Cav1 scaffolds are structurally and functionally
distinct from caveolae (30). Expression of Cav1 at low levels can
result in the assembly of stable oligomerized Cav1 microdomains,
or scaffolds, comprised of ∼15 Cav1 molecules (78, 83, 84). How-
ever, the role of noncaveolar Cav1 remains elusive.
In conclusion, we report that Cav1 is involved in the transduction
of TCR signals required for optimal regulation of integrin adhesion
and function in primary CD8 T cells. These findings support the
emerging view that membrane adaptor proteins serve as check-
points for controlling signaling thresholds and cellular output. TCR
signaling pathways are not linear but diverge, facilitated by nu-
merous membrane adaptors, which may include Cav1. Integrin
signaling is fundamental to T cell activation and plays a major role
in the formation of the IS, cell adhesion, and migration. Cav1 is
clearly involved in these processes in primary T cells and is there-
fore a potential target for manipulation of TCR signals to improve
T effector function during an immune response.
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Supplementary Figure 1. Lymphoid organs express low levels of Cav1,
Cav2 and PTRF mRNA. Fold change relative to LN of (A) Cav1, (B)
Cav2 and (C) PTRF mRNA levels normalized to 18S RNA in secondary
lymphoid and non-lymphoid organs. Data is representative of 1 or 3
independent experiments. (D) EM identification of caveolae-like
structures (indicated by arrow) in A431 cells but not naïve CD8 T cells.
Scale bar 100nm.
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Supplementary Figure 2. Imagestream analytical workflow for identifying 1:1
heteroconjugates and measuring CD11a in the IS. (A) Bi-varate plot of integrated CTV
fluorescence intensity (x) versus same for MitoTDR intensity (y). Gate identifies putative
double stained events. Example multi-spectral images shown below for each major region (i-
iii). (B) Bi-varate plot of BF Area (x) versus Aspect Ratio of the same (y). Gate captures events
formed from two conjoined cells. Example multispectral images are shown from outside this
gate (iv) and within (v). (C) Bi-varate plot of integrated BODIPY-Fl fluorescence intensity (x)
versus the same for CD11a Pe (y). Gate captures all double positive events. Example
multispectral images are shown from within this gate (vi). (D) Cells also gated for 7-AAD
positivity prior to constructing the interface mask shown in panel M. Mask key: 1. BF image
(CH01) no mask shown; 2. BF image (CH01), default mask (M01) overlaid; 3. BF image
(CH01), synapse mask, Interface (M07, M05, M08) mask overlaid; 4. 7-AAD image (CH05),
Interface (M07, M05, M08) mask overlaid; 5. BODIPY-Fl image (CH02), Interface (M07, M05,
M08) mask overlaid. (E) Internalization score for each verified conjugate was calculated for
BODIPY-Fl (vii) and CD11a (viii). Median internalization score was reported. (F) A typical matrix
spillover coefficients is presented, calculated from the IDEAS compensation wizard using
single stained controls (BODIPY-Fl (B-Fl), Pe, 7-AAD, CTV and MitoTDR).
